Correlation Between SIS and Krebs Biochemicals

Can any of the company-specific risk be diversified away by investing in both SIS and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SIS and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SIS LIMITED and Krebs Biochemicals and, you can compare the effects of market volatilities on SIS and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SIS with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of SIS and Krebs Biochemicals.

Diversification Opportunities for SIS and Krebs Biochemicals

-0.51

Correlation Coefficient

SIS  Krebs Biochemicals

Excellent diversification

The 3 months correlation between SIS and Krebs is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding SIS LIMITED and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and SIS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SIS LIMITED are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of SIS i.e., SIS and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between SIS and Krebs Biochemicals

Assuming the 90 days trading horizon SIS LIMITED is expected to generate 0.4 times more return on investment than Krebs Biochemicals. However, SIS LIMITED is 2.51 times less risky than Krebs Biochemicals. It trades about -0.43 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about -0.19 per unit of risk. If you would invest  39,240  in SIS LIMITED on October 9, 2024 and sell it today you would lose (4,065) from holding SIS LIMITED or give up 10.36% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SIS LIMITED  vs.  Krebs Biochemicals and

SIS LIMITED

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SIS LIMITED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Krebs Biochemicals and

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SIS and Krebs Biochemicals

The main advantage of trading using opposite SIS and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SIS position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.

The idea behind SIS LIMITED and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.